{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T18:50:05Z","timestamp":1781808605036,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s40264-024-01482-w","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T02:10:10Z","timestamp":1727230210000},"page":"87-97","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Use of Multiple Medications During Pregnancy Among an Ethnically Diverse Population in South-Eastern Melbourne: A Retrospective Analysis to Explore Potential Risks and Complications"],"prefix":"10.1007","volume":"48","author":[{"given":"Yitayeh","family":"Belsti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten R.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja Ram","family":"Dhungana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Callander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Lorber","family":"Rolnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Teede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4480-5690","authenticated-orcid":false,"given":"Joanne","family":"Enticott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"1482_CR1","unstructured":"Australian Institute of Health and Welfare. Australia\u2019s mothers and babies, maternal age. 2023. Available from: https:\/\/www.aihw.gov.au\/reports\/mothers-babies\/australias-mothers-babies\/contents\/overview-and-demographics\/maternal-age. Accessed 10 Jan 2024."},{"issue":"5","key":"1482_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.puhe.2005.10.015","volume":"120","author":"J Brynhildsen","year":"2006","unstructured":"Brynhildsen J, Sydsj\u00f6 A, Norinder E, Selling KE, Sydsj\u00f6 G. Trends in body mass index during early pregnancy in Swedish women 1978\u20132001. Public Health. 2006;120(5):393\u20139. https:\/\/doi.org\/10.1016\/j.puhe.2005.10.015.","journal-title":"Public Health"},{"issue":"1","key":"1482_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12884-022-04442-3","volume":"22","author":"SI Lee","year":"2022","unstructured":"Lee SI, Azcoaga-Lorenzo A, Agrawal U, Kennedy JI, Fagbamigbe AF, Hope H, et al. Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study. BMC Pregnancy Childbirth. 2022;22(1):120. https:\/\/doi.org\/10.1186\/s12884-022-04442-3.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"1482_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"A Afshin","year":"2017","unstructured":"Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, GBD 2015 Obesity Collaborators, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1614362.","journal-title":"N Engl J Med"},{"key":"1482_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.872490","volume":"9","author":"R Hu","year":"2022","unstructured":"Hu R, Yin H, Li X. Changing trends of adverse pregnancy outcomes with maternal pre-pregnancy body mass index: a join-point analysis. Front Med (Lausanne). 2022;9: 872490. https:\/\/doi.org\/10.3389\/fmed.2022.872490.","journal-title":"Front Med (Lausanne)."},{"issue":"9","key":"1482_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002665","volume":"15","author":"JG Beeson","year":"2018","unstructured":"Beeson JG, Homer CS, Morgan C, Menendez C. Multiple morbidities in pregnancy: time for research, innovation, and action. PLoS Med. 2018;15(9): e1002665. https:\/\/doi.org\/10.1371\/journal.pmed.1002665.","journal-title":"PLoS Med"},{"issue":"1","key":"1482_CR7","doi-asserted-by":"publisher","first-page":"51.e1","DOI":"10.1016\/j.ajog.2011.02.029","volume":"205","author":"AA Mitchell","year":"2011","unstructured":"Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hern\u00e1ndez-D\u00edaz S, et al. Medication use during pregnancy, with particular focus on prescription drugs: 1976\u20132008. Am J Obstet Gynecol. 2011;205(1):51.e1-8. https:\/\/doi.org\/10.1016\/j.ajog.2011.02.029.","journal-title":"Am J Obstet Gynecol"},{"issue":"9836","key":"1482_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(12)60240-2.","journal-title":"Lancet"},{"issue":"1","key":"1482_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13023-023-02992-z","volume":"19","author":"S Baldacci","year":"2024","unstructured":"Baldacci S, Santoro M, Mezzasalma L, Pierini A, Coi A. Medication use during pregnancy and the risk of gastroschisis: a systematic review and meta-analysis of observational studies. Orphanet J Rare Dis. 2024;19(1):31. https:\/\/doi.org\/10.1186\/s13023-023-02992-z.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"1482_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0306-3356(21)00006-6","volume":"13","author":"L Beeley","year":"1986","unstructured":"Beeley L. Adverse effects of drugs in the first trimester of pregnancy. Clin Obstet Gynaecol. 1986;13(2):177\u201395. https:\/\/doi.org\/10.1016\/S0306-3356(21)00006-6.","journal-title":"Clin Obstet Gynaecol"},{"issue":"4","key":"1482_CR11","first-page":"50","volume":"7","author":"VA Dobiesz","year":"2018","unstructured":"Dobiesz VA, Robinson DW. Drug therapy in pregnancy. Mortality. 2018;7(4):50\u20131.","journal-title":"Mortality"},{"issue":"1","key":"1482_CR12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12884-018-2081-x","volume":"18","author":"AZ Leke","year":"2018","unstructured":"Leke AZ, Dolk H, Loane M, Casson K, Maboh NM, Maeya SE, et al. First trimester medication use in pregnancy in Cameroon: a multi-hospital survey. BMC Pregnancy Childbirth. 2018;18(1):450. https:\/\/doi.org\/10.1186\/s12884-018-2081-x.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"1482_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067585","volume":"13","author":"A Anand","year":"2023","unstructured":"Anand A, Phillips K, Subramanian A, Lee SI, Wang Z, McCowan R, et al. Prevalence of polypharmacy in pregnancy: a systematic review. BMJ Open. 2023;13(3): e067585. https:\/\/doi.org\/10.1136\/bmjopen-2022-067585.","journal-title":"BMJ Open"},{"issue":"22","key":"1482_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033828","volume":"102","author":"YC Chang","year":"2023","unstructured":"Chang YC, Huang HY, Shen TH, Wu CH. Prevalence, trends, and characteristics of polypharmacy among US pregnant women aged 15 to 44 years: NHANES 1999 to 2016. Med (Baltim). 2023;102(22): e33828. https:\/\/doi.org\/10.1097\/MD.0000000000033828.","journal-title":"Med (Baltim)."},{"issue":"42","key":"1482_CR15","volume":"10","author":"H Jackson","year":"2023","unstructured":"Jackson H, Grzeskowiak L, Enticott J, Wise S, Callander E. How the structural determinants of health inequities impact access to prescription medication for pregnant women in Australia: a narrative review. Lancet Reg Health West Pac. 2023;10(42): 100934.","journal-title":"Lancet Reg Health West Pac."},{"issue":"Suppl. 7(Suppl.","key":"1482_CR16","doi-asserted-by":"publisher","first-page":"S437","DOI":"10.1093\/cid\/ciu709","volume":"59","author":"JS Sheffield","year":"2014","unstructured":"Sheffield JS, Siegel D, Mirochnick M, Heine RP, Nguyen C, Bergman KL, et al. Designing drug trials: considerations for pregnant women. Clin Infect Dis. 2014;59(Suppl. 7(Suppl. 7)):S437\u201344. https:\/\/doi.org\/10.1093\/cid\/ciu709.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1482_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/bdrc.21096","volume":"105","author":"N Vargesson","year":"2015","unstructured":"Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C Embryo Today. 2015;105(2):140\u201356. https:\/\/doi.org\/10.1002\/bdrc.21096 (PMID26043938).","journal-title":"Birth Defects Res C Embryo Today"},{"issue":"2","key":"1482_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/ppe.12733","volume":"35","author":"BT Bateman","year":"2021","unstructured":"Bateman BT, Huybrechts KF. Drug-drug interactions in pregnancy: an important frontier for pharmacoepidemiology. Paediatr Perinat Epidemiol. 2021;35(2):194\u20135. https:\/\/doi.org\/10.1111\/ppe.12733.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"1482_CR19","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.17535.1","volume":"8","author":"SJ Stock","year":"2019","unstructured":"Stock SJ, Norman JE. Medicines in pregnancy. F1000Res. 2019;8:F1000. https:\/\/doi.org\/10.12688\/f1000research.17535.1.","journal-title":"F1000Res"},{"issue":"1","key":"1482_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12910-023-00924-x","volume":"24","author":"MJ Hollestelle","year":"2023","unstructured":"Hollestelle MJ, van der Graaf R, Sturkenboom MC, van Delden JJ. Stimulating solidarity to improve knowledge on medications used during pregnancy: a contribution from the ConcePTION project. BMC Med Ethics. 2023;24(1):44. https:\/\/doi.org\/10.1186\/s12910-023-00924-x.","journal-title":"BMC Med Ethics"},{"issue":"5","key":"1482_CR21","doi-asserted-by":"publisher","first-page":"10778","DOI":"10.1097\/AOG.0b013e3182a9ca67","volume":"122","author":"KE Shields","year":"2013","unstructured":"Shields KE, Lyerly AD. Exclusion of pregnant women from industry-sponsored clinical trials. Obstet Gynecol. 2013;122(5):10778\u201381. https:\/\/doi.org\/10.1097\/AOG.0b013e3182a9ca67.","journal-title":"Obstet Gynecol"},{"issue":"9715","key":"1482_CR22","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/s0140-6736(10)60257-7","volume":"375","author":"R Macklin","year":"2010","unstructured":"Macklin R. Enrolling pregnant women in biomedical research. Lancet. 2010;375(9715):632\u20133. https:\/\/doi.org\/10.1016\/s0140-6736(10)60257-7.","journal-title":"Lancet"},{"issue":"1","key":"1482_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12916-015-0322-7","volume":"13","author":"B Guthrie","year":"2015","unstructured":"Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995\u20132010. BMC Med. 2015;13(1):74. https:\/\/doi.org\/10.1186\/s12916-015-0322-7.","journal-title":"BMC Med"},{"issue":"9","key":"1482_CR24","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/pds.1984","volume":"19","author":"FT Bourgeois","year":"2010","unstructured":"Bourgeois FT, Shannon MW, Valim C, Mandl KD. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf. 2010;19(9):901\u201310. https:\/\/doi.org\/10.1002\/pds.1984 (PMID20623513).","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"342","key":"1482_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d3514","volume":"21","author":"B Guthrie","year":"2011","unstructured":"Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ. 2011;21(342): d3514. https:\/\/doi.org\/10.1136\/bmj.d3514.","journal-title":"BMJ"},{"issue":"13","key":"1482_CR26","doi-asserted-by":"publisher","first-page":"175628642096950","DOI":"10.1177\/1756286420969501","volume":"19","author":"N Frahm","year":"2020","unstructured":"Frahm N, Hecker M, Langhorst SE, Mashhadiakbar P, Haker MC, Zettl UK. The risk of polypharmacy, comorbidities and drug-drug interactions in women of childbearing age with multiple sclerosis. Ther Adv Neurol Disord. 2020;19(13):1756286420969501. https:\/\/doi.org\/10.1177\/1756286420969501.","journal-title":"Ther Adv Neurol Disord"},{"issue":"11","key":"1482_CR27","doi-asserted-by":"publisher","first-page":"806","DOI":"10.14740\/jocmr3557w","volume":"10","author":"J Peabody","year":"2018","unstructured":"Peabody J, Acelajado MC, Robert T, Hild C, Schrecker J, Paculdo D, et al. Drug-drug interaction assessment and identification in the primary care setting. J Clin Med Res. 2018;10(11):806\u201314. https:\/\/doi.org\/10.14740\/jocmr3557w.","journal-title":"J Clin Med Res"},{"key":"1482_CR28","unstructured":"Monash Women\u2019s Press. Maternity care with Monash. Available from: https:\/\/monashwomens.org\/. Accessed 28 Aug 2023."},{"key":"1482_CR29","unstructured":"Australian Institute of Health and Welfare. Australia\u2019s mothers and babies, place of birth. 2023. Available from: https:\/\/www.aihw.gov.au\/reports\/mothers-babies\/australias-mothers-babies\/contents\/labour-and-birth\/place-of-birth. Accessed 15 Jan 2024."},{"key":"1482_CR30","unstructured":"The Commonwealth Fund. Mirror 2021: reflecting poorly. 2021. Available from: https:\/\/www.commonwealthfund.org\/publications\/fund-reports\/2021\/aug\/mirror-mirror-2021-reflecting-poorly. Accessed 7 Sep 2024."},{"key":"1482_CR31","unstructured":"\u200c31. The Commonwealth Fund. Maternal mortality and maternity care in the United States compared to 10 other developed countries. 2020. Available from: https:\/\/www.commonwealthfund.org\/publications\/issue-briefs\/2020\/nov\/maternal-mortality-maternity-care-us-compared-10-countries. Accessed 16 Jan 2024."},{"key":"1482_CR32","unstructured":"Australian Bureau of Statistics. Main features: IRSD. 2016. Available from: https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/Lookup\/by%20Subject\/2033.0.55.001~2016~Main%20Features~IRSD~19. Accessed 7 Sep 2024."},{"key":"1482_CR33","doi-asserted-by":"publisher","unstructured":"Medication use during pregnancy in mainland China: a cross-sectional analysis of a National Health Insurance database. Available from: https:\/\/doi.org\/10.2147\/CLEP.S230589. Accessed 18 Jun 2024.","DOI":"10.2147\/CLEP.S230589"},{"issue":"5","key":"1482_CR34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s11096-012-9665-8","volume":"34","author":"M Odalovic","year":"2012","unstructured":"Odalovic M, Vezmar Kovacevic S, Ilic K, Sabo A, Tasic L. Drug use before and during pregnancy in Serbia. Int J Clin Pharm. 2012;34(5):719\u201327. https:\/\/doi.org\/10.1007\/s11096-012-9665-8.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"1482_CR35","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/pds.1906","volume":"19","author":"BJ Cleary","year":"2010","unstructured":"Cleary BJ, Butt H, Strawbridge JD, Gallagher PJ, Fahey T, Murphy DJ. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women. Pharmacoepidemiol Drug Saf. 2010;19(4):408\u201317. https:\/\/doi.org\/10.1002\/pds.1906.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"1482_CR36","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00228-008-0546-y","volume":"64","author":"JJ Gagne","year":"2008","unstructured":"Gagne JJ, Maio V, Berghella V, Louis DZ, Gonnella JS. Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna. Italy Eur J Clin Pharmacol. 2008;64(11):1125\u201332. https:\/\/doi.org\/10.1007\/s00228-008-0546-y.","journal-title":"Italy. Eur J Clin Pharmacol."},{"issue":"3","key":"1482_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/CLEP.S16305","volume":"1","author":"O Stephansson","year":"2011","unstructured":"Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H. Drug use during pregnancy in Sweden: assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol. 2011;1(3):43\u201350. https:\/\/doi.org\/10.2147\/CLEP.S16305.","journal-title":"Clin Epidemiol"},{"issue":"3","key":"1482_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00737-012-0278-y","volume":"15","author":"H Nordeng","year":"2012","unstructured":"Nordeng H, Hansen C, Garthus-Niegel S, Eberhard-Gran M. Fear of childbirth, mental health, and medication use during pregnancy. Arch Womens Ment Health. 2012;15(3):203\u20139. https:\/\/doi.org\/10.1007\/s00737-012-0278-y.","journal-title":"Arch Womens Ment Health"},{"issue":"9","key":"1482_CR39","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/pds.4577","volume":"27","author":"A Engeland","year":"2018","unstructured":"Engeland A, Bj\u00f8rge T, Klungs\u00f8yr K, Hjellvik V, Skurtveit S, Furu K. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015. Pharmacoepidemiol Drug Saf. 2018;27(9):995\u20131004. https:\/\/doi.org\/10.1002\/pds.4577 (PMID29920833).","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"1482_CR40","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/AOG.0000000000002579","volume":"131","author":"DM Haas","year":"2018","unstructured":"Haas DM, Marsh DJ, Dang DT, Parker CB, Wing DA, Simhan HN, et al. Prescription and other medication use in pregnancy. Obstet Gynecol. 2018;131(5):789\u201398. https:\/\/doi.org\/10.1097\/AOG.0000000000002579.","journal-title":"Obstet Gynecol"},{"key":"1482_CR41","unstructured":"PubMed. Drug prescription in pregnancy: analysis of a large statutory sickness fund population. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15480609\/. Accessed 19 Jun 2024."},{"issue":"2","key":"1482_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004365","volume":"4","author":"A Lupattelli","year":"2014","unstructured":"Lupattelli A, Spigset O, Twigg MJ, Zagorodnikova K, M\u00e5rdby AC, Moretti ME, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open. 2014;4(2): e004365. https:\/\/doi.org\/10.1136\/bmjopen-2013-004365.","journal-title":"BMJ Open"},{"issue":"1","key":"1482_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12916-022-02722-5","volume":"21","author":"A Subramanian","year":"2023","unstructured":"Subramanian A, Azcoaga-Lorenzo A, Anand A, Phillips K, Lee SI, Cockburn N, et al. Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000\u20132019. BMC Med. 2023;21(1):21. https:\/\/doi.org\/10.1186\/s12916-022-02722-5.","journal-title":"BMC Med"},{"key":"1482_CR44","unstructured":"Australian Institute of Family Studies. Births in Australia. Available from: https:\/\/aifs.gov.au\/research\/facts-and-figures\/births-australia-2023. Accessed 2 Aug 2023."},{"key":"1482_CR45","unstructured":"Australian Institute of Health and Welfare. Australia\u2019s mothers and babies, maternal body mass index. 2023. Available from: https:\/\/www.aihw.gov.au\/reports\/mothers-babies\/australias-mothers-babies-data-visualisations\/contents\/antenatal-period\/body-mass-index. Accessed 2 Aug 2023."},{"key":"1482_CR46","unstructured":"Australian Institute of Health and Welfare. Impact of overweight and obesity as a risk factor for chronic conditions: Australian Burden of Disease Study Series 11, 2017. Available from: https:\/\/www.aihw.gov.au\/getmedia\/f8618e51-c1c4-4dfb-85e0-54ea19500c91\/20700.pdf.aspx?inline=true. Accessed 13 Aug 2024."},{"issue":"4","key":"1482_CR47","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S2213-8587(22)00033-X","volume":"10","author":"M Kivim\u00e4ki","year":"2022","unstructured":"Kivim\u00e4ki M, Strandberg T, Pentti J, Nyberg ST, Frank P, Jokela M, et al. Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study. Lancet Diabetes Endocrinol. 2022;10(4):253\u201363. https:\/\/doi.org\/10.1016\/S2213-8587(22)00033-X.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"1482_CR48","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.3390\/jcm12082830","volume":"12","author":"M Mirabelli","year":"2023","unstructured":"Mirabelli M, Tocci V, Donnici A, Giuliano S, Sarnelli P, Salatino A, et al. Maternal preconception body mass index overtakes age as a risk factor for gestational diabetes mellitus. J Clin Med. 2023;12(8):2830. https:\/\/doi.org\/10.3390\/jcm12082830.","journal-title":"J Clin Med"},{"issue":"2","key":"1482_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.7570\/jomes20110","volume":"30","author":"TR Flores","year":"2021","unstructured":"Flores TR, Rodrigues AP, Neves RG, Batista SR, Teixeira DS, da Silveira EA, et al. The risk of multimorbidity associated with overweight and obesity: data from the Brazilian national health survey 2013. J Obes Metab Syndr. 2021;30(2):155\u201362. https:\/\/doi.org\/10.7570\/jomes20110.","journal-title":"J Obes Metab Syndr."},{"key":"1482_CR50","unstructured":"Australian Institute of Health and Welfare. Reporting on the health of culturally and linguistically diverse populations in Australia: an exploratory paper, summary. 2022. Available from: https:\/\/www.aihw.gov.au\/reports\/cald-australians\/reporting-health-cald-populations\/summary. Accessed 10 Jan 2024."},{"key":"1482_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev.psych.57.102904.190212","volume":"58","author":"VM Mays","year":"2007","unstructured":"Mays VM, Cochran SD, Barnes NW. Race, race-based discrimination, and health outcomes among African Americans. Annu Rev Psychol. 2007;58:201\u201325. https:\/\/doi.org\/10.1146\/annurev.psych.57.102904.190212.","journal-title":"Annu Rev Psychol"},{"issue":"2","key":"1482_CR52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2105\/ajph.93.2.277","volume":"93","author":"JY Nazroo","year":"2003","unstructured":"Nazroo JY. The structuring of ethnic inequalities in health: economic position, racial discrimination, and racism. Am J Public Health. 2003;93(2):277\u201384. https:\/\/doi.org\/10.2105\/ajph.93.2.277 (PMID12554585).","journal-title":"Am J Public Health"},{"issue":"4","key":"1482_CR53","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/ije\/dyl056","volume":"35","author":"Y Paradies","year":"2006","unstructured":"Paradies Y. A systematic review of empirical research on self-reported racism and health. Int J Epidemiol. 2006;35(4):888\u2013901. https:\/\/doi.org\/10.1093\/ije\/dyl056.","journal-title":"Int J Epidemiol"},{"issue":"7447","key":"1482_CR54","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/bmj.328.7447.1070","volume":"328","author":"N Pearce","year":"2004","unstructured":"Pearce N, Foliaki S, Sporle A, Cunningham C. Genetics, race, ethnicity, and health. BMJ. 2004;328(7447):1070\u20132. https:\/\/doi.org\/10.1136\/bmj.328.7447.1070.","journal-title":"BMJ"},{"issue":"3","key":"1482_CR55","doi-asserted-by":"publisher","first-page":"e32840","DOI":"10.1371\/journal.pone.0032840","volume":"7","author":"CY Cheng","year":"2012","unstructured":"Cheng CY, Reich D, Haiman CA, Tandon A, Patterson N, Selvin E, et al. African ancestry and its correlation to type 2 diabetes in African Americans: a genetic admixture analysis in three U.S. population cohorts. PLoS ONE. 2012;7(3):e32840. https:\/\/doi.org\/10.1371\/journal.pone.0032840.","journal-title":"PLoS ONE"},{"issue":"5","key":"1482_CR56","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00125-012-2486-4","volume":"55","author":"L Qi","year":"2012","unstructured":"Qi L, Nassir R, Kosoy R, Garcia L, Curb JD, Tinker L, et al. Relationship between diabetes risk and admixture in postmenopausal African-American and Hispanic-American women. Diabetologia. 2012;55(5):1329\u201337. https:\/\/doi.org\/10.1007\/s00125-012-2486-4.","journal-title":"Diabetologia"},{"issue":"2","key":"1482_CR57","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ajpa.24144","volume":"175","author":"K Batai","year":"2021","unstructured":"Batai K, Hooker S, Kittles RA. Leveraging genetic ancestry to study health disparities. Am J Phys Anthropol. 2021;175(2):363\u201375. https:\/\/doi.org\/10.1002\/ajpa.24144.","journal-title":"Am J Phys Anthropol"},{"issue":"3","key":"1482_CR58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000368191","volume":"61","author":"PS Nishtala","year":"2015","unstructured":"Nishtala PS, Salahudeen MS. Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005\u20132013. Gerontology. 2015;61(3):195\u2013202. https:\/\/doi.org\/10.1159\/000368191.","journal-title":"Gerontology"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-024-01482-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-024-01482-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-024-01482-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T19:45:39Z","timestamp":1741031139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-024-01482-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1482"],"URL":"https:\/\/doi.org\/10.1007\/s40264-024-01482-w","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"assertion":[{"value":"22 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open Access funding enabled and organized by CAUL and its Member Institutions. This study received no specific funding. AM, HT, KRP, and DR are supported by fellowships from the Australian National Health and Medical Research Council. YB is supported by the Monash Graduate Scholarship and Monash International Tuition Scholarship.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"Ethical permission to access the de-identified data and conduct this research was obtained from Monash Health with the ethics approval number RES-21-0000-183L. The research was conducted in adherence to the Code of Ethics of the World Medical Association, also known as the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The Monash Health Human Research and Ethics Committee can consider all data access requests via research support services at research@monashhealth.org.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"All code access requests can be forwarded to the corresponding author.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"YB, HJ, and JE were involved in the acquisition of data, conception, design, or planning of the study; and drafting of the manuscript. All the remaining authors were involved in the interpretation of the results and critically reviewing and revising the manuscript for important intellectual content. All authors have read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}